Standard Dosage Range
Research dosing range: 0.5–1 mg (hypoglycemia); varies (obesity research)
Educational reference only
Dosage by Use Case
Emergency Hypoglycemia (severe)
Single use
Administer subcutaneously, intramuscularly, or intravenously. Monitor blood glucose and repeat in 15 minutes if no response.
Emergency Hypoglycemia (nasal powder)
Single use
Administer nasally (Baqsimi). No need to inhale; absorbed through nasal mucosa. Monitor blood glucose and repeat in 15 minutes if no response.
GI Diagnostic Procedures
Single use
Administered IV or IM to relax smooth muscle. Dosage varies depending on procedure and patient.
Obesity Research (multi-agonist)
Varies
Glucagon receptor agonism is being investigated in multi-agonist drugs (e.g., survodutide, retatrutide) for weight loss and metabolic benefits. Dosing regimens are still under clinical investigation.
Timing & Frequency
For emergency hypoglycemia, administer immediately upon recognition of symptoms. For GI procedures, administer prior to the procedure as directed by medical personnel.
Cycle Guidance
Not applicable for emergency use. For research purposes with multi-agonist drugs, follow the specific clinical trial protocol.
Reconstitution Reference
Quick reference for reconstituting Glucagon. For custom vial sizes and concentrations, use the Reconstitution Calculator.
| Common Vial Size | Varies by product (e.g., 1 mg for GlucaGen) |
| BAC Water Volume | Follow manufacturer instructions |
| Concentration & Draw | Follow manufacturer instructions for reconstitution and concentration. |
| Storage | Follow manufacturer instructions for storage and stability. |
| Stability | Follow manufacturer instructions for storage and stability. |
Frequently Asked Questions
How quickly does glucagon work for hypoglycemia?
What are the side effects of glucagon?
Last updated: 2026-02-19